Online inquiry

IVTScrip™ mRNA-Anti-GP, REGN3470-3471-3479(Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) (CAT#: GTTS-WQ13968MR)

This product GTTS-WQ13968MR is a type of mRNA modified with N1-Methylpseudo-UTP, which ecodes the monoclonal antibody that targets GP gene. The antibody can be applied in Ebola virus infection research.

Specifications
Product type	mRNA
Modified bases	N1-Methylpseudo-UTP
5' Cap	Cap 1
Species	Homo sapiens
RefSeq	NP_066246.1
Applications	Gene therapy research
Format	Powder
Quantity	100 µg
Purification	oligo-dT affinity purification

Target Gene
Gene ID	911829
UniProt ID	Q05320

Download
Download resources about mRNA therapeutics development to boost your research.

CUSTOMER REVIEWS and Q&As
There are currently no Customer reviews or questions for IVTScrip™ mRNA-Anti-GP, REGN3470-3471-3479(Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) (GTTS-WQ13968MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT	Product Name	Product Type	CDs
GTTS-WQ9879MR	IVTScrip™ mRNA-Anti-pcrV, KB001-A(Cap 0, Pseudo-UTP, 120 nt-poly(A))	mRNA	KB001-A
GTTS-WQ14809MR	IVTScrip™ mRNA-Anti-CD70, SGN-70(Cap 1, Pseudo-UTP, 30 nt-poly(A))	mRNA	SGN-70
GTTS-WQ3868MR	IVTScrip™ mRNA-Anti-IL6R, BCD-089(Cap 1, 2-Thio-UTP, 120 nt-poly(A))	mRNA	BCD-089
GTTS-WQ9558MR	IVTScrip™ mRNA-Anti-TNFRSF17, J6M0(Cap 1, 2-Thio-UTP, 30 nt-poly(A))	mRNA	J6M0
GTTS-WQ15292MR	IVTScrip™ mRNA-Anti-EGFR, Theraloc(Cap 0, Pseudo-UTP, 30 nt-poly(A))	mRNA	Theraloc
GTTS-WQ4092MR	IVTScrip™ mRNA-Anti-oxLDL, BI-204(Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A))	mRNA	BI-204
GTTS-WQ13748MR	IVTScrip™ mRNA-Anti-ANGPTL3, REGN 1500(Cap 1, 5-Methoxy-UTP, 120 nt-poly(A))	mRNA	REGN 1500
GTTS-WQ2141MR	IVTScrip™ mRNA-Anti-CGRP, ALD-403(Cap 0, 2-Thio-UTP, 30 nt-poly(A))	mRNA	ALD-403

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST